Exagen Inc. XGN Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$3.97M-5.7% | -$4.67M-24.2% | -$7.09M-41.0% | -$4.44M-49.7% | -$3.75M-11.7% | ||
| $655K+57.1% | $705K+62.8% | $593K+173% | $443K-20.9% | $417K-24.6% | ||
| $133K+217% | $131K+212% | $126K+271% | $79K+92.7% | $42K+13.5% | ||
| $4.92M-28.7% | —— | —— | —— | $6.89M+58.5% | ||
| -$41K-118% | $587K-74.9% | $1.03M+185% | -$1.81M-318% | $231K+114% | ||
| -$1.56M-9.8% | $681K— | $1.18M— | -$192K+37.7% | -$1.42M+0.9% | ||
| -$172K-139% | -$298K-2,192% | -$206K— | -$216K-350% | -$72K-33.3% | ||
| $99K+234% | $0+100% | -$69K+66.5% | -$4K— | -$74K— | ||
| $6K-95.8% | —— | -$375K— | $140K— | $143K— | ||
| -$295K-12.2% | -$288K-12.5% | -$275K-12.2% | -$270K-12.5% | -$263K-11.9% | ||
| -$10.42M+2.4% | -$3.01M— | —— | -$2.89M-18.9% | -$10.67M-18.0% | ||
| $228K+102% | $44K-69.9% | $275K+87.1% | $209K+53.7% | $113K+31.4% | ||
| $0-100% | $9K— | —— | —— | $6K— | ||
| -$228K-113% | -$35K+76.0% | -$275K-87.1% | -$209K-53.7% | -$107K-24.4% | ||
| $168K+57.0% | $165K— | $162K— | $158K+343% | $107K+64.6% | ||
| $295K+49.0% | —— | —— | $18.58M— | $198K— | ||
| $189K+110% | $181K+63.1% | $174K+55.4% | $49K-61.7% | $90K-35.3% | ||
| $0-100% | $0— | $199K— | $605K— | $65K— | ||
| -$62K+3.1% | $0+100% | $2.95M+2,538% | $21.93M+9,805% | -$64K+36.0% | ||
| -$10.71M+1.2% | —— | $5.62M+330% | $18.84M+776% | -$10.84M-17.5% | ||
| $856K+113% | $880K+114% | $885K+103% | $820K+87.6% | $402K-7.4% | ||
| $133K+217% | $131K+212% | $126K+271% | $79K+92.7% | $42K+13.5% | ||
| $661K— | $277K— | $300K— | $200K— | $0— | ||
| $599K+36.1% | $600K+44.6% | $612K+45.0% | $466K+8.6% | $440K-3.9% | ||
| -$1.56M-9.8% | $681K— | $1.18M— | -$192K+37.7% | -$1.42M+0.9% | ||
| -$295K-12.2% | -$288K-12.5% | -$275K-12.2% | -$270K-12.5% | -$263K-11.9% | ||
| $1.14M+57,100% | —— | -$560K-17.4% | -$796K-309% | -$2K+99.6% | ||
| $256K+9.4% | $250K+9.6% | —— | —— | $234K— | ||
| $99K+234% | $0+100% | -$69K+66.5% | -$4K— | -$74K— | ||
| $0-100% | $9K— | —— | —— | $6K— | ||
| $189K+110% | $181K+63.1% | $174K+55.4% | $49K-61.7% | $90K-35.3% | ||
| $0-100% | $0— | $199K— | $605K— | $65K— | ||
| $295K+49.0% | $0— | $199K+176% | $1K— | $198K+90.4% | ||
| $168K+57.0% | $165K+57.1% | $162K+57.3% | $158K+61.2% | $107K+64.6% | ||
| $72K-59.1% | $8K-98.9% | $17K— | -$176K-633% | $176K+2,833% | ||
| —— | $819.75K— | $819.75K— | $819.75K— | $819.75K— | ||
| -$882K— | —— | $2.67M— | $438K— | $0— | ||
| $6K-95.8% | —— | -$375K— | $140K— | $143K— | ||
| -$295K-12.2% | -$288K-12.5% | -$275K-12.2% | -$270K-12.5% | -$263K-11.9% | ||
| $0-100% | $0— | $2.55M— | $5K— | $677K— | ||
| -$10.65M+1.3% | -$3.06M— | —— | -$3.09M-20.8% | -$10.78M-18.2% | ||
| -$10.65M+1.3% | -$3.06M— | —— | -$3.09M-20.8% | -$10.78M-18.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Exagen Inc. generate?
- Exagen Inc. (XGN) generated -$27.0M in operating cash flow over the trailing twelve months.
- What is Exagen Inc.'s free cash flow?
- After $756.0K of capital expenditures, Exagen Inc.'s free cash flow was -$27.6M over the trailing twelve months, down 96.9% year over year.
- Where does Exagen Inc.'s cash flow data come from?
- Every line is extracted from Exagen Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
